Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3
- Liakina, V.
- Hamid, S.
- Tanaka, J.
- Olafsson, S.
- Sharara, A. I.
- Alavian, S. M.
- Gheorghe, L.
- El Hassan, E. S.
- Abaalkhail, F.
- Abbas, Z.
- Abdou, A.
- Abourached, A.
- Al Braiki, F.
- Al Hosani, F.
- Al Jaberi, K.
- Al Khatry, M.
- Al Mulla, M. A.
- Al Quraishi, H.
- Al Rifai, A.
- Al Serkal, Y.
- Alam, A.
- Alashgar, H. I.
- Alawadhi, S.
- Al-Dabal, L.
- Aldins, P.
- Alfaleh, F. Z.
- Alghamdi, A. S.
- Al-Hakeem, R.
- Aljumah, A. A.
- Almessabi, A.
- Alqutub, A. N.
- Alswat, K. A.
- Altraif, I.
- Alzaabi, M.
- Andrea, N.
- Assiri, A. M.
- Babatin, M. A.
- Baqir, A.
- Barakat, M. T.
- Bergmann, O. M.
- Bizri, A. R.
- Blach, S.
- Chaudhry, A.
- Choi, M. S.
- Diab, T.
- Djauzi, S.
- El Khoury, S.
- Estes, C.
- Fakhry, S.
- Farooqi, J. I.
- Fridjonsdottir, H.
- Gani, R. A.
- Ghafoor Khan, A.
- Goldis, A.
- Gottfredsson, M.
- Gregorcic, S.
- Hajarizadeh, B.
- Han, K. H.
- Hasan, I.
- Hashim, A.
- Horvath, G.
- Hunyady, B.
- Husni, R.
- Jafri, W.
- Jeruma, A.
- Jonasson, J. G.
- Karlsdottir, B.
- Kim, D. Y.
- Kim, Y. S.
- Koutoubi, Z.
- Lesmana, L. A.
- Lim, Y. S.
- Löve, A.
- Maimets, M.
- Makara, M.
- Malekzadeh, R.
- Matičič, M.
- Memon, M. S.
- Merat, S.
- Mokhbat, J. E.
- Mourad, F. H.
- Muljono, D. H.
- Nawaz, A.
- Nugrahini, N.
- Priohutomo, S.
- Qureshi, H.
- Rassam, P.
- Razavi, H.
- Razavi-Shearer, D.
- Razavi-Shearer, K.
- Rozentale, B.
- Sadik, M.
- Saeed, K.
- Salamat, A.
- Salupere, R.
- Sanai, F. M.
- Sanityoso Sulaiman, A.
- Sayegh, R. A.
- Schmelzer, J. D.
- Sibley, A.
- Siddiq, M.
- Siddiqui, A. M.
- Sigmundsdottir, G.
- Sigurdardottir, B.
- Speiciene, D.
- Sulaiman, A.
- Sultan, M. A.
- Taha, M.
- Tarifi, H.
- Tayyab, G.
- Tolmane, I.
- Ud Din, M.
- Umar, M.
- Valantinas, J.
- Videčnik-Zorman, J.
- Yaghi, C.
- Yunihastuti, E.
- Yusuf, M. A.
- Zuberi, B. F.
- Gunter, J.
DOIAbstract
Publisher Copyright: © 2015 John Wiley & Sons Ltd.Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 ...
Add to ORKG